NCT02903862

Brief Summary

The purposes of this study are to (1) track dementia caregiver health indicators over 12 weeks, both with and without the Mindoula plus DANA intervention (case manager and mobile messaging and assessment applications) to determine if the intervention improves caregiver health and (2) obtain feedback from caregivers to inform on the design of future interventions.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2016

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 3, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 16, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

July 3, 2018

Status Verified

June 1, 2018

Enrollment Period

1 year

First QC Date

August 3, 2016

Last Update Submit

June 29, 2018

Conditions

Keywords

CaregiversCase ManagementAlzheimer's DiseaseCognitionCaregiver BurdenDepression

Outcome Measures

Primary Outcomes (1)

  • Change from baseline M3 Behavioral Scale score over 12 weeks

    At baseline, and 4, 8, and 12 weeks.

Secondary Outcomes (2)

  • Change from baseline Zarit Burden Inventory score over 12 weeks

    At baseline, and 4, 8, and 12 weeks.

  • Change from baseline PROMIS Sleep Disturbance Short Form 8a score over 12 weeks

    At baseline, and 4, 8, and 12 weeks.

Other Outcomes (3)

  • Usability Questionnaire

    At baseline, and 4, 8, and 12 weeks.

  • Paired Associates Learning

    At baseline and 12 weeks

  • PERMA Profiler

    At baseline and 12 weeks

Study Arms (2)

Intervention Arm

EXPERIMENTAL

Participants will receive the intervention, Mindoula plus DANA, which involves working with a case manager via an app for 12 weeks. The case manager will help the participant cope with the stresses of caregiving as well as remind them to use the DANA cognitive assessment app. This arm will also take the study's psychological surveys.

Behavioral: MindoulaDevice: DANA

Waitlist Control Arm

OTHER

These participants will take psychological surveys and a usability questionnaire for the first 12 weeks of participation, then, for the 12 weeks following, take the psychological surveys along with DANA and a usability questionnaire.

Device: DANA

Interventions

MindoulaBEHAVIORAL

The Mindoula intervention is a combination of case management and a messenger application. Case managers monitor how the participant is doing and any needs and provide 24/7 support \& assistance, including care coordination, treatment adherence, and matching the participant with providers and community resources. Each participant will be given an intake questionnaire to establish goals and behavioral health history. Participants will use the app and work with the case manager for 12 weeks.

Intervention Arm
DANADEVICE

DANA is an FDA-cleared neurocognitive assessment software administered on a smartphone or tablet to measure changes in cognitive efficiency. DANA also includes Ecological Momentary Assessments to track mood, sleep, stress, and memory. Intervention participants will take DANA weekly. The Waitlist Control arm will take DANA weekly 12 weeks after enrollment.

Intervention ArmWaitlist Control Arm

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Females and males who regularly provide care for a person with Alzheimer's Disease
  • Between the ages of 45-75
  • Self-reported ability to speak and read English
  • Providing care for at least a year
  • Zarit Burden Inventory (ZBI) Score of 9+
  • Overall M3 score of 33+
  • M3 Depression score of 7+
  • Female Only
  • Minimum hours of caregiving a week must be equal to or greater than 20 hours

You may not qualify if:

  • Anyone with a known cognitive diagnosis
  • Anyone with color blindness
  • Overall score of high risk on the M3 and/or high risk on the PTSD or Bipolar subsection of the M3

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AnthroTronix Inc

Silver Spring, Maryland, 20910, United States

Location

Related Publications (1)

  • Lathan C, Wallace AS, Shewbridge R, Ng N, Morrison G, Resnick HE. Cognitive Health Assessment and Establishment of a Virtual Cohort of Dementia Caregivers. Dement Geriatr Cogn Dis Extra. 2016 Mar 22;6(1):98-107. doi: 10.1159/000444390. eCollection 2016 Jan-Apr.

    PMID: 27099613BACKGROUND

Related Links

MeSH Terms

Conditions

DepressionAlzheimer DiseaseCaregiver Burden

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersStress, Psychological

Study Officials

  • Corinna E Lathan, Ph.D

    AnthroTronix, Inc.

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2016

First Posted

September 16, 2016

Study Start

July 1, 2016

Primary Completion

July 1, 2017

Study Completion

July 1, 2017

Last Updated

July 3, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share

Locations